Abstract
The increasing occurrence of antibiotic-resistant pathogens influences the treatment approach to respiratory tract infections and complicates the selection of the anti-infectious drug and dosing regimen. Pharmacokinetic (PK) and pharmacodynamic (PD) characteristics both influence dosing regimens of antimicrobials. PK (the overall disposition of the drug in the body) is reflected by the serum concentration profile over time. PD can be characterized by the susceptibility of the pathogen to the drug, determined by measuring the minimum inhibitory concentration (MIC), which is a potency of the drug. There is an increasing need to identify new therapeutic approaches which improve the chance to reduce the morbidity and obtain successful outcomes. So far, antibiotic dosing has been focused on PK concepts, mainly the penetration of drug into sites of infection and its elimination half-life. Recently, a new appealing approach integrating PK and PD features has been suggested to implement optimal antibiotic dosing regimens, since several studies in animals and humans found a striking correlation between bacteriological outcome and specific PK/PD indices. It appears it would lead to better results not only in terms of clinical and bacteriological cure but also in the whole patient care.
Keywords: Antibiotics, MIC, pharmacokinetic/pharmacodynamic indices, respiratory tract infection
Current Respiratory Medicine Reviews
Title: Antibiotic Dosage Regimens in Respiratory Tract Infections in the Pharmacokinetic/Pharmacodynamic Era
Volume: 2 Issue: 1
Author(s): D. Soy, J. R. Badia and A. Torres
Affiliation:
Keywords: Antibiotics, MIC, pharmacokinetic/pharmacodynamic indices, respiratory tract infection
Abstract: The increasing occurrence of antibiotic-resistant pathogens influences the treatment approach to respiratory tract infections and complicates the selection of the anti-infectious drug and dosing regimen. Pharmacokinetic (PK) and pharmacodynamic (PD) characteristics both influence dosing regimens of antimicrobials. PK (the overall disposition of the drug in the body) is reflected by the serum concentration profile over time. PD can be characterized by the susceptibility of the pathogen to the drug, determined by measuring the minimum inhibitory concentration (MIC), which is a potency of the drug. There is an increasing need to identify new therapeutic approaches which improve the chance to reduce the morbidity and obtain successful outcomes. So far, antibiotic dosing has been focused on PK concepts, mainly the penetration of drug into sites of infection and its elimination half-life. Recently, a new appealing approach integrating PK and PD features has been suggested to implement optimal antibiotic dosing regimens, since several studies in animals and humans found a striking correlation between bacteriological outcome and specific PK/PD indices. It appears it would lead to better results not only in terms of clinical and bacteriological cure but also in the whole patient care.
Export Options
About this article
Cite this article as:
Soy D., Badia R. J. and Torres A., Antibiotic Dosage Regimens in Respiratory Tract Infections in the Pharmacokinetic/Pharmacodynamic Era, Current Respiratory Medicine Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339806775486218
DOI https://dx.doi.org/10.2174/157339806775486218 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endocarditis Due to Salmonella Enterica Subsp. Arizonae in a Patient with Sickle Cell Disease: A Case Report and Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Therapeutic Modulation of Cytokines in Chronic Infectious Diseases
Current Pharmaceutical Design New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design Immunoinformatic Approach for the Identification of Potential Epitopes Against <i>Stenotrophomonas maltophilia</i>: A Global Opportunistic Pathogen
Letters in Drug Design & Discovery Pharmacology of Cyclic Peptides: Vancomycin and Oxytocin as Paradigms
Protein & Peptide Letters Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery Elucidating Protein-protein Interactions Through Computational Approaches and Designing Small Molecule Inhibitors Against them for Various Diseases
Current Topics in Medicinal Chemistry Current Concepts of Immunopathogenesis, Diagnosis and Therapy in Whipples Disease
Current Medicinal Chemistry Prediction Models and Scores in Adult Congenital Heart Disease
Current Pharmaceutical Design Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Current Medical Imaging Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Proteomic and Bioinformatics Tools to Understand Virulence Mechanisms in Staphylococcus aureus
Current Proteomics DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Preface
Recent Patents on Anti-Infective Drug Discovery The Use of Phages for the Removal of Infectious Biofilms
Current Pharmaceutical Biotechnology